NCT04137991View on ClinicalTrials.gov

Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2021

Conditions

Nociceptive PainGoal-directed TherapyHemodynamic InstabilityNol-IndexRemifentanilCardiac SurgeryVascular SurgeryGeneral Anesthesia

Interventions

DEVICE

Nol-Index guided analgesia

Monitor that indicates the level of nociception-antinociception balance

OTHER

Standard Analgesia

Administration of remifentanil based guided by heart rate, blood pressure, and experience

Trial Locations (1)

Unknown

Anesthesia Department, Erasme Hospital, Brussels

All Listed Sponsors

lead

Erasme University Hospital

OTHER

NCT04137991 - Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery | Biotech Hunter | Biotech Hunter